BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 33358704)

  • 1. RTS,S/AS01
    Suau R; Vidal M; Aguilar R; Ruiz-Olalla G; Vázquez-Santiago M; Jairoce C; Nhabomba AJ; Gyan B; Dosoo D; Asante KP; Owusu-Agyei S; Campo JJ; Izquierdo L; Cavanagh D; Coppel RL; Chauhan V; Angov E; Dutta S; Gaur D; Beeson JG; Moncunill G; Dobaño C
    Vaccine; 2021 Jan; 39(4):687-698. PubMed ID: 33358704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S/AS01E vaccination in African children.
    Ubillos I; Ayestaran A; Nhabomba AJ; Dosoo D; Vidal M; Jiménez A; Jairoce C; Sanz H; Aguilar R; Williams NA; Díez-Padrisa N; Mpina M; Sorgho H; Agnandji ST; Kariuki S; Mordmüller B; Daubenberger C; Asante KP; Owusu-Agyei S; Sacarlal J; Aide P; Aponte JJ; Dutta S; Gyan B; Campo JJ; Valim C; Moncunill G; Dobaño C
    BMC Med; 2018 Oct; 16(1):197. PubMed ID: 30376866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study.
    Dobaño C; Ubillos I; Jairoce C; Gyan B; Vidal M; Jiménez A; Santano R; Dosoo D; Nhabomba AJ; Ayestaran A; Aguilar R; Williams NA; Díez-Padrisa N; Lanar D; Chauhan V; Chitnis C; Dutta S; Gaur D; Angov E; Asante KP; Owusu-Agyei S; Valim C; Gamain B; Coppel RL; Cavanagh D; Beeson JG; Campo JJ; Moncunill G
    BMC Med; 2019 Aug; 17(1):157. PubMed ID: 31409398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong off-target antibody reactivity to malarial antigens induced by RTS,S/AS01E vaccination is associated with protection.
    Macià D; Campo JJ; Moncunill G; Jairoce C; Nhabomba AJ; Mpina M; Sorgho H; Dosoo D; Traore O; Kusi KA; Williams NA; Oberai A; Randall A; Sanz H; Valim C; Asante KP; Owusu-Agyei S; Tinto H; Agnandji ST; Kariuki S; Gyan B; Daubenberger C; Mordmüller B; Petrone P; Dobaño C
    JCI Insight; 2022 May; 7(10):. PubMed ID: 35446785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of immunization schedule with the malaria vaccine candidate RTS,S/AS01E on protective efficacy and anti-circumsporozoite protein antibody avidity in African infants.
    Ajua A; Lell B; Agnandji ST; Asante KP; Owusu-Agyei S; Mwangoka G; Mpina M; Salim N; Tanner M; Abdulla S; Vekemans J; Jongert E; Lievens M; Cambron P; Ockenhouse CF; Kremsner PG; Mordmüller B
    Malar J; 2015 Feb; 14():72. PubMed ID: 25885325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial.
    Olotu A; Lusingu J; Leach A; Lievens M; Vekemans J; Msham S; Lang T; Gould J; Dubois MC; Jongert E; Vansadia P; Carter T; Njuguna P; Awuondo KO; Malabeja A; Abdul O; Gesase S; Mturi N; Drakeley CJ; Savarese B; Villafana T; Lapierre D; Ballou WR; Cohen J; Lemnge MM; Peshu N; Marsh K; Riley EM; von Seidlein L; Bejon P
    Lancet Infect Dis; 2011 Feb; 11(2):102-9. PubMed ID: 21237715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Patterns of IgG Subclass Responses to
    Dobaño C; Santano R; Vidal M; Jiménez A; Jairoce C; Ubillos I; Dosoo D; Aguilar R; Williams NA; Díez-Padrisa N; Ayestaran A; Valim C; Asante KP; Owusu-Agyei S; Lanar D; Chauhan V; Chitnis C; Dutta S; Angov E; Gamain B; Coppel RL; Beeson JG; Reiling L; Gaur D; Cavanagh D; Gyan B; Nhabomba AJ; Campo JJ; Moncunill G
    Front Immunol; 2019; 10():439. PubMed ID: 30930896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Immunogenicity of Seven Dosing Regimens of the Candidate RTS,S/AS01E Malaria Vaccine Integrated Within an Expanded Program on Immunization Regimen: A Phase II, Single-Center, Open, Controlled Trial in Infants in Malawi.
    Witte D; Cunliffe NA; Turner AM; Ngulube E; Ofori-Anyinam O; Vekemans J; Chimpeni P; Lievens M; Wilson TP; Njiram'madzi J; Mendoza YG; Leach A
    Pediatr Infect Dis J; 2018 May; 37(5):483-491. PubMed ID: 29432383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy.
    Dobaño C; Sanz H; Sorgho H; Dosoo D; Mpina M; Ubillos I; Aguilar R; Ford T; Díez-Padrisa N; Williams NA; Ayestaran A; Traore O; Nhabomba AJ; Jairoce C; Waitumbi J; Agnandji ST; Kariuki S; Abdulla S; Aponte JJ; Mordmüller B; Asante KP; Owusu-Agyei S; Tinto H; Campo JJ; Moncunill G; Gyan B; Valim C; Daubenberger C
    Nat Commun; 2019 May; 10(1):2174. PubMed ID: 31092823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.
    Asante KP; Abdulla S; Agnandji S; Lyimo J; Vekemans J; Soulanoudjingar S; Owusu R; Shomari M; Leach A; Jongert E; Salim N; Fernandes JF; Dosoo D; Chikawe M; Issifou S; Osei-Kwakye K; Lievens M; Paricek M; Möller T; Apanga S; Mwangoka G; Dubois MC; Madi T; Kwara E; Minja R; Hounkpatin AB; Boahen O; Kayan K; Adjei G; Chandramohan D; Carter T; Vansadia P; Sillman M; Savarese B; Loucq C; Lapierre D; Greenwood B; Cohen J; Kremsner P; Owusu-Agyei S; Tanner M; Lell B
    Lancet Infect Dis; 2011 Oct; 11(10):741-9. PubMed ID: 21782519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.
    Bejon P; Lusingu J; Olotu A; Leach A; Lievens M; Vekemans J; Mshamu S; Lang T; Gould J; Dubois MC; Demoitié MA; Stallaert JF; Vansadia P; Carter T; Njuguna P; Awuondo KO; Malabeja A; Abdul O; Gesase S; Mturi N; Drakeley CJ; Savarese B; Villafana T; Ballou WR; Cohen J; Riley EM; Lemnge MM; Marsh K; von Seidlein L
    N Engl J Med; 2008 Dec; 359(24):2521-32. PubMed ID: 19064627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Anti-Circumsporozoite Antibody Response of Children to Seasonal Vaccination With the RTS,S/AS01E Malaria Vaccine.
    Sagara I; Zongo I; Cairns M; Yerbanga RS; Mahamar A; Nikièma F; Tapily A; Sompougdou F; Diarra M; Zoungrana C; Issiaka D; Haro A; Sanogo K; Aziz Sienou A; Kaya M; Traore S; Thera I; Diarra K; Dolo A; Kuepfer I; Snell P; Milligan P; Ockenhouse C; Ofori-Anyinam O; Tinto H; Djimde A; Ouedraogo JB; Dicko A; Chandramohan D; Greenwood B
    Clin Infect Dis; 2022 Sep; 75(4):613-622. PubMed ID: 34894221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The duration of protection against clinical malaria provided by the combination of seasonal RTS,S/AS01
    Cairns M; Barry A; Zongo I; Sagara I; Yerbanga SR; Diarra M; Zoungrana C; Issiaka D; Sienou AA; Tapily A; Sanogo K; Kaya M; Traore S; Diarra K; Yalcouye H; Sidibe Y; Haro A; Thera I; Snell P; Grant J; Tinto H; Milligan P; Chandramohan D; Greenwood B; Dicko A; Ouedraogo JB
    BMC Med; 2022 Oct; 20(1):352. PubMed ID: 36203149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Helper T Cell Type 1 and 2 Responses Associated With Malaria Protection and Risk in RTS,S/AS01E Vaccinees.
    Moncunill G; Mpina M; Nhabomba AJ; Aguilar R; Ayestaran A; Sanz H; Campo JJ; Jairoce C; Barrios D; Dong Y; Díez-Padrisa N; Fernandes JF; Abdulla S; Sacarlal J; Williams NA; Harezlak J; Mordmüller B; Agnandji ST; Aponte JJ; Daubenberger C; Valim C; Dobaño C
    Clin Infect Dis; 2017 Sep; 65(5):746-755. PubMed ID: 28505356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children.
    Owusu-Agyei S; Ansong D; Asante K; Kwarteng Owusu S; Owusu R; Wireko Brobby NA; Dosoo D; Osei Akoto A; Osei-Kwakye K; Adjei EA; Boahen KO; Sylverken J; Adjei G; Sambian D; Apanga S; Kayan K; Vekemans J; Ofori-Anyinam O; Leach A; Lievens M; Demoitie MA; Dubois MC; Cohen J; Ballou WR; Savarese B; Chandramohan D; Gyapong JO; Milligan P; Antwi S; Agbenyega T; Greenwood B; Evans J
    PLoS One; 2009 Oct; 4(10):e7302. PubMed ID: 19806184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A monoclonal antibody-based immunoassay to measure the antibody response against the repeat region of the circumsporozoite protein of Plasmodium falciparum.
    Radin K; Clement F; Jongert E; Sterckx YG; Ockenhouse C; Regules J; Lemiale F; Leroux-Roels G
    Malar J; 2016 Nov; 15(1):543. PubMed ID: 27825382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults.
    Cummings JF; Polhemus ME; Kester KE; Ockenhouse CF; Gasser RA; Coyne P; Wortmann G; Nielsen RK; Schaecher K; Holland CA; Krzych U; Tornieporth N; Soisson LA; Angov E; Heppner DG;
    Vaccine; 2024 Apr; 42(12):3066-3074. PubMed ID: 38584058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial.
    White MT; Verity R; Griffin JT; Asante KP; Owusu-Agyei S; Greenwood B; Drakeley C; Gesase S; Lusingu J; Ansong D; Adjei S; Agbenyega T; Ogutu B; Otieno L; Otieno W; Agnandji ST; Lell B; Kremsner P; Hoffman I; Martinson F; Kamthunzu P; Tinto H; Valea I; Sorgho H; Oneko M; Otieno K; Hamel MJ; Salim N; Mtoro A; Abdulla S; Aide P; Sacarlal J; Aponte JJ; Njuguna P; Marsh K; Bejon P; Riley EM; Ghani AC
    Lancet Infect Dis; 2015 Dec; 15(12):1450-8. PubMed ID: 26342424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure.
    Kurtovic L; Agius PA; Feng G; Drew DR; Ubillos I; Sacarlal J; Aponte JJ; Fowkes FJI; Dobaño C; Beeson JG
    BMC Med; 2019 Feb; 17(1):45. PubMed ID: 30798787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
    Olotu A; Moris P; Mwacharo J; Vekemans J; Kimani D; Janssens M; Kai O; Jongert E; Lievens M; Leach A; Villafana T; Savarese B; Marsh K; Cohen J; Bejon P
    PLoS One; 2011; 6(10):e25786. PubMed ID: 21998698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.